Francesco Verderame Selected Research

Paclitaxel (Taxol)

2/2024	Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.
10/2023	Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.
9/2023	Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Verderame Research Topics

Disease

8	Neoplasms (Cancer) 03/2024 - 06/2018
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 02/2003
6	Prostatic Neoplasms (Prostate Cancer) 12/2019 - 01/2015
5	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2006
4	Neoplasm Metastasis (Metastasis) 03/2024 - 01/2015
3	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 11/2023
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2024 - 11/2019
3	Triple Negative Breast Neoplasms 02/2024 - 09/2023
3	Human Influenza (Influenza) 11/2023 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 03/2006
2	Brain Neoplasms (Brain Tumor) 06/2022 - 01/2019
2	Neutropenia 01/2021 - 09/2008
2	Febrile Neutropenia 01/2021 - 09/2008
1	Mesothelioma 02/2024
1	Lung Neoplasms (Lung Cancer) 12/2023
1	Disease Progression 11/2023
1	Heart Arrest (Cardiac Arrest) 01/2021
1	Multiple Organ Failure (MODS) 01/2021
1	Enterocolitis 01/2021
1	Dehydration (Water Stress) 01/2021
1	Pancytopenia 01/2021
1	Sudden Death 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Pulmonary Embolism 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Sepsis (Septicemia) 01/2021
1	Hepatitis 01/2021
1	COVID-19 01/2020
1	Osteolysis 04/2018
1	Hemangiosarcoma (Angiosarcoma) 03/2017
1	Adenocarcinoma 03/2006

Drug/Important Bio-Agent (IBA)

5	NivolumabIBA 02/2024 - 01/2019
5	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2020
5	Vinorelbine (Navelbine)FDA LinkGeneric 01/2020 - 02/2003
4	Etoposide (VP 16)FDA LinkGeneric 02/2024 - 11/2019
4	PlatinumIBA 06/2022 - 01/2019
4	Docetaxel (Taxotere)FDA Link 02/2016 - 04/2014
3	Paclitaxel (Taxol)FDA LinkGeneric 02/2024 - 09/2023
3	durvalumabIBA 06/2022 - 11/2019
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 02/2003
3	Abiraterone AcetateIBA 02/2016 - 05/2015
2	atezolizumabIBA 02/2024 - 09/2023
2	Carboplatin (JM8)FDA LinkGeneric 02/2024 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 02/2024 - 12/2023
2	Gemcitabine FDA Link 04/2014 - 02/2003
1	Yttrium-90IBA 03/2024
1	Sorafenib (BAY 43-9006)FDA Link 02/2024
1	130-nm albumin-bound paclitaxelIBA 09/2023
1	ribociclibIBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2022
1	Aromatase InhibitorsIBA 01/2022
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2021
1	tremelimumabIBA 01/2021
1	Radium-223IBA 12/2019
1	eribulin FDA Link 01/2019
1	Therapeutic UsesIBA 04/2018
1	RadiopharmaceuticalsIBA 04/2018
1	RadiumIBA 04/2018
1	enzalutamideIBA 07/2015
1	cabazitaxel FDA Link 07/2015
1	nasIBA 07/2015
1	abirateroneIBA 01/2015
1	Trastuzumab (Herceptin)FDA Link 04/2014
1	AcidsIBA 07/2006
1	Fluorouracil (Carac)FDA LinkGeneric 07/2006
1	Cetuximab (Erbitux)FDA Link 03/2006
1	Irinotecan (Camptosar)FDA LinkGeneric 03/2006
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2006
1	Ifosfamide FDA LinkGeneric 02/2003

Therapy/Procedure

10	Therapeutics 12/2023 - 03/2006
5	Castration 12/2019 - 01/2015
5	Drug Therapy (Chemotherapy) 01/2019 - 03/2006
4	Immunotherapy 02/2024 - 01/2020
2	Radiotherapy 06/2022 - 12/2019
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 06/2018 - 03/2017
1	Investigational Therapies (Experimental Therapy) 12/2023
1	Cranial Irradiation 06/2022
1	Off-Label Use 04/2018
1	Intravenous Infusions 03/2006